Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 506 entries
View as:

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00461292 Org: User:
Start: 05/31/07 End: 04/30/10 Due: 04/30/11

A Safety and Effectiveness Study of JUVÉDERM VOLBELLA® XC Injectable Gel for Lip and Perioral Enhancement

Phase: N/A Priority: Normal
NCT ID: NCT01998581 Org: User:
Start: 11/01/13 End: 05/29/15 Due: 05/29/16

An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01785836 Org: User:
Start: 03/31/13 End: 10/31/13 Due: 10/31/14

Eluxadoline Bile Acid Malabsorption (BAM) Study

Phase: N/A Priority: Normal
NCT ID: NCT03441581 Org: User:
Start: 02/23/18 End: 04/28/20 Due: 04/28/21

A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006)

Phase: N/A Priority: Normal
NCT ID: NCT01613248 Org: User:
Start: 07/01/12 End: 12/01/12 Due: 12/01/13

Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT04303897 Org: User:
Start: 12/19/19 End: 03/03/22 Due: 03/03/23

Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Correction of Temple Hollowing

Phase: N/A Priority: Normal
NCT ID: NCT03166618 Org: User:
Start: 04/24/17 End: 07/21/17 Due: 07/21/18

Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease

Phase: N/A Priority: Normal
NCT ID: NCT03226769 Org: User:
Start: 07/26/17 End: 12/12/17 Due: 12/12/18

Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00332345 Org: User:
Start: 07/31/99 End: 08/31/99 Due: 08/31/00

Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01229423 Org: User:
Start: 11/30/09 End: 10/31/10 Due: 10/31/11

Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function

Phase: N/A Priority: Normal
NCT ID: NCT00076687 Org: User:
Start: 10/31/03 End: 08/31/09 Due: 08/31/10

Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia

Phase: N/A Priority: Normal
NCT ID: NCT02197806 Org: User:
Start: 07/31/14 End: 11/30/14 Due: 11/30/15

Reliability of a Masseter Muscle Prominence Scale and Lower Facial Shape Classification

Phase: N/A Priority: Normal
NCT ID: NCT01821534 Org: User:
Start: 03/31/13 End: 05/31/13 Due: 05/31/14

Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%

Phase: N/A Priority: Normal
NCT ID: NCT00827255 Org: User:
Start: 01/31/09 End: 10/31/09 Due: 10/31/10

A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT01732757 Org: User:
Start: 11/30/12 End: 12/31/12 Due: 12/31/13

Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT01852045 Org: User:
Start: 07/02/13 End: 10/11/18 Due: 10/11/19

Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle Hypertrophy

Phase: N/A Priority: Normal
NCT ID: NCT02010775 Org: User:
Start: 01/20/14 End: 11/29/17 Due: 11/29/18

Clinical Trial Evaluation of a Test Serum Post HEV (High Energy Visible) Light Exposure

Phase: N/A Priority: Normal
NCT ID: NCT03594721 Org: User:
Start: 08/06/18 End: 08/30/18 Due: 08/30/19

Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea

Phase: N/A Priority: Normal
NCT ID: NCT02555761 Org: User:
Start: 10/19/15 End: 03/19/18 Due: 03/19/19

BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT01603641 Org: User:
Start: 11/05/12 End: 08/25/18 Due: 08/25/19

Bladder Management in Patients With Multiple Sclerosis: Optimizing Practice Patterns

Phase: N/A Priority: Normal
NCT ID: NCT01930799 Org: User:
Start: 08/31/13 End: 03/31/15 Due: 03/31/16

Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)

Phase: N/A Priority: Normal
NCT ID: NCT03003416 Org: User:
Start: 10/19/17 End: 12/19/18 Due: 12/19/19

A Natural History Study of Patients With Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT00833235 Org: User:
Start: 02/01/09 End: 03/06/17 Due: 03/06/18

Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT01294384 Org: User:
Start: 05/01/11 End: 09/25/12 Due: 09/25/13

Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00332540 Org: User:
Start: 08/31/01 End: 08/31/03 Due: 08/31/04